Tukysa 150 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FSD25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,675
Award facts
- Contract value 100% obligated
- $12,674.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
TUKYSA is a specialized oncology medication used in cancer treatment, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies through its DLA contract vehicle to support military healthcare programs and Defense Health Agency requirements. The company's federal contract portfolio demonstrates consistent capability in delivering diverse pharmaceutical commodities—including specialty medications, brand-name and generic drugs, and medical supplies—across multiple therapeutic domains to federal customers including the U.S. Coast Guard and other government healthcare systems. This delivery order exemplifies the operational flexibility of the SPE2DX contract in meeting specific, time-sensitive medical supply requirements for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FSD25?
SPE2DB25FSD25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FSD25 worth?
The government has obligated $12,675 on SPE2DB25FSD25.
Is contract SPE2DB25FSD25 an order under another contract?
Yes. SPE2DB25FSD25 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FSD25 competed?
The extent of competition for SPE2DB25FSD25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award